The interaction of GSK3β
with cyclin D1 in different stages oral cancer progression. (A) The interaction of GSK3β with cyclin D1 in various oral tumor extracts (T1-T2 TE lane 3–5 & 11–13 and T3-T4 TE in lane 6–8 and 14–16). The input IgG and IgG adsorbed in TEs served as controls. (B) The expression levels of GSK3β, pSer9GSK3β, cyclin D1 and β-actin in the TEs were checked in the TEs used for interaction studies. (C) No significant correlation was observed in the interaction of GSK3β-cyclin D1 with the expression of various proteins as indicated.